Supplementary Methods from Discovery and characterization of ZL-2201, a potent, highly selective, and orally bioavailable small-molecule DNA-PK inhibitor

DOI: 10.1158/2767-9764.23912672.v1 Publication Date: 2023-08-09T14:40:27Z